SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-147274
Filing Date
2020-05-20
Accepted
2020-05-20 16:03:03
Documents
92
Period of Report
2020-05-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d932350d8k.htm   iXBRL 8-K 212522
2 EX-23.1 d932350dex231.htm EX-23.1 2234
3 EX-99.1 d932350dex991.htm   iXBRL EX-99.1 1440272
  Complete submission text file 0001193125-20-147274.txt   9542381

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA flxn-20200331.xsd EX-101.SCH 68081
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flxn-20200331_cal.xml EX-101.CAL 67452
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flxn-20200331_def.xml EX-101.DEF 285069
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20200331_lab.xml EX-101.LAB 599502
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20200331_pre.xml EX-101.PRE 467882
33 EXTRACTED XBRL INSTANCE DOCUMENT d932350d8k_htm.xml XML 2034673
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36287 | Film No.: 20898087
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences